Revolo Biotherapeutics Revenue and Competitors
Estimated Revenue & Valuation
- Revolo Biotherapeutics's estimated annual revenue is currently $4.2M per year.
- Revolo Biotherapeutics's estimated revenue per employee is $155,000
Employee Data
- Revolo Biotherapeutics has 27 Employees.
- Revolo Biotherapeutics grew their employee count by 0% last year.
Revolo Biotherapeutics's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Chief Financial Officer | Reveal Email/Phone |
2 | Chief Communications Officer (CCO) | Reveal Email/Phone |
3 | VP, CMC | Reveal Email/Phone |
4 | VP Regulatory Affairs | Reveal Email/Phone |
5 | EVP, Clinical Strategy, Development, and Operations | Reveal Email/Phone |
6 | VP, CMC | Reveal Email/Phone |
7 | Director, Human Resources and Senior Executive Administration | Reveal Email/Phone |
8 | Director, Chemistry, Manufacturing, and Controls (CMC) | Reveal Email/Phone |
9 | President and Chief Business Officer | Reveal Email/Phone |
10 | Director Clinical Operations | Reveal Email/Phone |
Revolo Biotherapeutics Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $99.4M | 458 | 40% | N/A | N/A |
#2 | $20.6M | 133 | 22% | N/A | N/A |
#3 | $156.1M | 146 | -70% | $145M | N/A |
#4 | $3.5M | 45 | -25% | $150M | N/A |
#5 | $1.6M | 21 | 0% | $459.5M | N/A |
#6 | $67.3M | 310 | 16% | $180.7M | N/A |
#7 | $8.5M | 55 | -2% | N/A | N/A |
#8 | $256.3M | 1025 | 9% | $168.5M | N/A |
#9 | $2.8M | 18 | -33% | N/A | N/A |
#10 | $9.1M | 59 | -9% | N/A | N/A |
What Is Revolo Biotherapeutics?
N/A
Total Funding
27
Number of Employees
$4.2M
Revenue (est)
0%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Revolo Biotherapeutics News
2022-03-30 - Global Biopharmaceutical Contract Manufacturing Market Report 2022: Market
is Projected to Reach $27.86 Billion by 2028 from $15,735.04 Million in 2021
Recently, Revolo Biotherapeutics entered into a partnership with contract development and manufacturing organization (CDMO) - Northway...
2022-03-30 - Biopharmaceutical Contract Manufacturing Market Research 2022 - COVID-19
Impact and Global Analysis by Downstream, Upstream, Fill and Finish,
Analytical and Quality Control, Packaging - ResearchAndMarkets.com
Recently, Revolo Biotherapeutics entered into a partnership with contract development and manufacturing organization (CDMO) - Northway...
Other Companies in
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $1.8M | 27 | 0% | $122.8M |
#2 | $4.6M | 27 | 0% | N/A |
#3 | $4.8M | 27 | -4% | N/A |
#4 | $2.7M | 27 | N/A | N/A |
#5 | $2.7M | 27 | N/A | N/A |